Belgium Data Desk › Health › Registry Next-Generation-Sequencing (NGS) tests for oncology
Registry Next-Generation-Sequencing (NGS) tests for oncology
The pilot study aims to introduce the NGS technology in our public health system and is realized through an agreement (convention) between (private) laboratories and hospitals and the NIHDI for a reimbursement of NGS tests in oncology and hemato-oncology.
- Publisher
- Sciensano
- Licence
- ODC-BY
Open licence — reuse allowed, usually with attribution - Topic
- Health
- Type
- Dataset
- Last updated (catalogue)
- 2026-08-11
- Formats
- CSV, JSON, HTML
- Contact
- info@sciensano.be
Open in Belgium Data DeskPreview, profile and run SQL in your browser
Official page at the publisher ↗
Download link checked on 2026-10-04: 3 of 3 worked. This page describes catalogue information. It does not state that the data is correct.
More in this topic
- ATMO-Street annual high-resolution model outputsBelgian Interregional Environment Agency · No licence stated in the catalogue
- NomenSoft coordinated reference tablesRIZIV / INAMI · No licence stated in the catalogue
- NomenSoft update filesRIZIV / INAMI · No licence stated in the catalogue
- PM10 rolling 24h mean — station featuresBelgian Interregional Environment Agency · No licence stated in the catalogue
- RIO annual/daily results by communeBelgian Interregional Environment Agency · No licence stated in the catalogue
More from this publisher
- AgMask - Evaluation of the types, efficacy and health risks of silver-based biocides used to impart antimicrobial properties to face masks worn during the COVID-19 crisis.Sciensano · Open licence · ✓
- Belgian Cystic Fibrosis RegistrySciensano · Open licence · ✓
- Belgian Early Warning System for DrugsSciensano · Open licence · ✓
- Belgian HIV/AIDS Cohort StudySciensano · Open licence · ✓